Skip to main navigation Skip to search Skip to main content

Toxicokinetics and Safety Ratios

  • Ferdi Sombogaard*
  • *Corresponding author for this work
  • Amsterdam UMC - University of Amsterdam

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

21 Downloads (Pure)

Abstract

Pharmacokinetics is essentially the study of “how a substance gets into the body and what happens to it in the body.” Similarly, toxicokinetics deals with what the body does with a drug or other substance when given a relatively high dose relative to the therapeutic dose. Toxicokinetic studies are generally carried out at much higher doses than those used in pharmacokinetic studies, and this dose information is critical for predicting the safety of substances. The primary objective of toxicokinetics is to describe the systemic exposure achieved in animals and its relationship to dose level and the time course of the toxicity study. The ratio of drug exposure in animals at the no observed adverse effect level (NOAEL) and in humans at the expected therapeutic dose is one of the precautionary principles to determine the risk benefit profile of pharmaceuticals.
Original languageEnglish
Title of host publicationDrug Discovery and Evaluation: Methods in Clinical Pharmacology, Second Edition
PublisherSpringer International Publishing
Pages949-956
ISBN (Electronic)9783319688640
ISBN (Print)9783319688633
DOIs
Publication statusPublished - 1 Jan 2020
Externally publishedYes

Publication series

NameDrug Discovery and Evaluation: Methods in Clinical Pharmacology, Second Edition

Fingerprint

Dive into the research topics of 'Toxicokinetics and Safety Ratios'. Together they form a unique fingerprint.

Cite this